These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 411726)

  • 41. A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome).
    Bhaumik M; Muller VJ; Rozaklis T; Johnson L; Dobrenis K; Bhattacharyya R; Wurzelmann S; Finamore P; Hopwood JJ; Walkley SU; Stanley P
    Glycobiology; 1999 Dec; 9(12):1389-96. PubMed ID: 10561464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycosaminoglycans in components of the rabbit eye: synthesis and characterization.
    Góes RM; Laicine EM; Porcionatto MA; Bonciani Nader H; Haddad A
    Curr Eye Res; 1999 Aug; 19(2):146-53. PubMed ID: 10420184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The mucopolysaccharidoses (a review).
    Dorfman A; Matalon R
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):630-7. PubMed ID: 813230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycosaminoglycan-degrading enzymes in the varicose vein wall.
    Kowalewski R; Sobolewski K; Malkowski A; Gacko M; Rutkowska I
    Int Angiol; 2008 Dec; 27(6):529-35. PubMed ID: 19078917
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mucopolysaccharidoses: inborn errors of glycosaminoglycan catabolism.
    Cantz M; Gehler J
    Hum Genet; 1976 Jun; 32(3):233-55. PubMed ID: 820626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mucopolysaccharides synthesized by cultured glial cells derived from a patient with Sanfilippo A syndrome.
    Fluharty AL; Davis ML; Trammell DJ; Stevens RL; Kihara H
    J Neurochem; 1975 Oct; 25(4):429-35. PubMed ID: 125314
    [No Abstract]   [Full Text] [Related]  

  • 47. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
    Toma L; Dietrich CP; Nader HB
    Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HGSNAT enzyme deficiency results in accumulation of heparan sulfate in podocytes and basement membranes.
    Nagel L; Oliveira R; Pshezhetsky AV; Morales CR
    Histol Histopathol; 2019 Dec; 34(12):1377-1385. PubMed ID: 31157913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The heterogeneity of dermatan sulfate and heparan sulfate in rat liver and a shift in the glycosaminoglycan contents in carbon tetrachloride-damaged liver.
    Suzuki S; Suzuki S; Nakamura N; Koizumi T
    Biochim Biophys Acta; 1976 Mar; 428(1):166-181. PubMed ID: 130930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormalities of glycosphingolipids in mucopolysaccharidosis type III B.
    Hara A; Kitazawa N; Taketomi T
    J Lipid Res; 1984 Feb; 25(2):175-84. PubMed ID: 6423755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.
    Coppa GV; Gabrielli O; Zampini L; Maccari F; Mantovani V; Galeazzi T; Santoro L; Padella L; Marchesiello RL; Galeotti F; Volpi N
    Metab Brain Dis; 2015 Dec; 30(6):1343-8. PubMed ID: 26016623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hurler's, Hunter's and Morquio's syndromes. A biochemical study in the light of current views of the underlying defects.
    Dean MF; Muir H; Ewins RJ
    Biochem J; 1971 Aug; 123(5):883-94. PubMed ID: 4256532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate.
    Sewell RF; Brenchley PE; Mallick NP
    Biochem J; 1989 Dec; 264(3):777-83. PubMed ID: 2533499
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of sulfated glycosaminoglycans in cultured endothelial cells and smooth muscle cells from bovine aorta.
    Gamse G; Fromme HG; Kresse H
    Biochim Biophys Acta; 1978 Dec; 544(3):514-28. PubMed ID: 728470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activities of some glycosaminoglycan- degrading enzymes in Wharton's jelly and their alteration in EPH-gestosis (Pre-eclampsia).
    Romanowicz L; Bańkowski E; Sobolewski K; Jaworski S
    Biol Neonate; 1999 Sep; 76(3):144-52. PubMed ID: 10460952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Enzymatic Degradation of Heparan Sulfate.
    Griffin LS; Gloster TM
    Protein Pept Lett; 2017; 24(8):710-722. PubMed ID: 28741461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and turnover of glycosaminoglycans in rat kidneys.
    Barry DN; Bowness JM
    Can J Biochem; 1975 Jun; 53(6):713-20. PubMed ID: 124622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolation and characterization of peptidoglycans in urine from patients with mucopolysaccharidoses.
    Tanaka Y; Takazono I
    Int J Biochem; 1984; 16(5):435-46. PubMed ID: 6233194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in cell-surface glycosaminoglycans in human diploid fibroblasts during in vitro aging.
    Matuoka K; Mitsui Y
    Mech Ageing Dev; 1981 Feb; 15(2):153-63. PubMed ID: 6453260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fractionation and characterization of urinary heparan sulfate excreted by patients with Sanfilippo syndrome.
    Kimura A; Hayashi S; Koseki M; Kochi H; Tsurumi K
    Tohoku J Exp Med; 1984 Nov; 144(3):227-36. PubMed ID: 6240800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.